Tag: financial restructuring
WuXi Considers Asset Sale Amidst BIOSECURE Act Uncertainty
Today, let's discuss the possibility of AI taking over cancer research, WuXi's decision to sell some of its operations due to the BIOSECURE Act,...
BREAKING NEWS
Bluebird Bio Sold to Carlyle, SK Capital for Under $30M
Bluebird Bio, a once-promising biotech company, made headlines recently with its decision to sell itself and its portfolio of gene therapies to investment firms...
